GUANGZHOU, China --- Bio-Thera Solutions (688177:SH), a commercial-stage biopharmaceutical company developing a pipeline of innovative therapies and biosimilars, and Accord BioPharma, Inc, the U.S. specialty division ofIntas Pharmaceuticals, Ltd.(&qu...
View DetailsGUANGZHOU, China --- Bio-Thera Solutions (688177:SH), a commercial-stage biopharmaceuticalcompany developing a pipeline of innovative therapies and biosimilars, todayannounced an expansion of its partnership with Intas Pharmaceuticals for BAT2506, ap...
Guangzhou, China / Jeddah, Saudi Arabia – September 15,2025 –Bio-Thera Solutions Inc.(688177:SH), a commercial-stage biopharmaceutical company developing a pipeline of innovative therapies and biosimilars Under the agreement, Jamjoom Pharma will obta...
Guangzhou,China– September 10, 2025 –Bio-TheraSolutions Inc. (688177:SH),a commercial-stage biopharmaceutical company developing a pipeline ofinnovative therapies and biosimilars, today announced that the MHRA hasapproved Qletli® (adalimumab), a bios...
